期刊文献+

核因子κB、白介素6在慢性阻塞性肺疾病发病机制中的作用 被引量:5

Role of IL-6 and NF-kappaB in patients with chronic obstructive pulmonary disease LUO Ze-ru , GAO Xing lin ,LI Dong-feng ,FENG Su-ling. Southern Medical University ,Guangzhou 510515 ,China
原文传递
导出
摘要 目的探讨核因子KB(NF-κB)、白介素6(IL-6)在慢性阻塞性肺疾病(COPD)的表达及意义。方法选择2012年2月至2012年7月呼吸科COPD急性加重期及稳定期患者各25例,无COPD的对照组25例,抽取静脉血,ELISA测定血浆IL-6的浓度,Westernblotting测定外周血单个核细胞的NFxB的表达水平,采用SPSS13.0进行统计分析它们是否有统计学差异及其相关性。结果①CRP在COPD急性加重期组、稳定期组、对照组浓度分别为(28.1257±38.5613)mg/L,(8.2055±16.3096)mg/L,(2.8617±4.8547)mg/L,急性加重期组较稳定期组及对照组有统计学的升高,稳定期组与对照组比较差异无统计学意义;②IL-6在COPD急性加重期组、稳定期组、对照组浓度分别为(31.8834±19.46295)ng/L,(44.461±16.1814)ng/L,(23.856±9.93033)ng/L,急性加重组、稳定期组与对照组比较差异有统计学意义;③NF-κB在COPD急性加重期组、稳定期组、对照组表达分别为(0.9659±0.0754),(0.9182±0.05131),(0.9496±0.14393),3组之间差异无统计学意义;④相关性分析显示NF—κB与IL-6之间无明显相关。结论COPD稳定期患者外周血IL-6表达明显增加,提示Il-6与气道的慢性炎症相关,可能与COPD的发病机制有关。COPD患者外周血单个核细胞NF—κB无明显升高,提示其不直接引起COPD患者的全身炎症。 Objective The expression and significance of nuclear factor-κB (NF-;B) and IL-6 were investigated in the peripheral blood of patients with chronic obstructive pulmonary disease (COPD). Methods From February through July 2012, the serum concentrations of IL-6 and the expression of NF-κB of peripheral blood mononuclear cells (PBMC) were compared, using ELISA and Western blotting, respectively, among patients with acute COPD (AECOPD, n =25),patients with stable COPD (SCOPD, n =25) and controls without COPD ( n =25). All the data were analysed using SPSS 13.0. Results ①The serum concentration of CRP was significantly higher in the AECOPD group (28. 125 7; 38. 561 3) mg/L, compared with the stable COPD group (8. 205 5 ± 16. 309 6) mg/L and the control group (2. 861 7±4. 854 7) mg/L. Nevertheless, there was no significant difference between the stable COPD group and the control group; ②The serum concentration of IL 6 was significantly higher in the AECOPD group (31. 883 4±19. 462 95) ng/L and the stable COPD group (44. 461±16.1814) ng/L, compared with the control group (23. 856±9. 930 33) ng/L;③The expression of N F-κB of PBMC were no significant difference in AECOPD group (0. 965 9;0. 075 4), stable group (0. 918 2!0. 051 31) and control group (0. 949 6±0. 143 93) ;④The correlation between the expression of NF-κB of PBMC and the serum concentration of IL-6 was insignificant. Conclusions may play a critical role in the pathogenesis of COPD, inflammation of COPD. The overexpression of IL-6 in in stable group but NF-κB was not concerned with systemic
出处 《国际呼吸杂志》 2013年第11期804-807,共4页 International Journal of Respiration
基金 广东省医学科研基金(A2012001)
关键词 慢性阻塞性肺疾病 白介素6 核因子ΚB Chronic obstructive pulmonary disease Interleukin-6 Nuclear factor-κB
  • 相关文献

参考文献14

  • 1Garcia-Rio F, Miravitlles M, Soriano JB, et al. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res, 2010,11 : 63.
  • 2Dal Negro RW, Visconti M, Micheletto C, et al. Changes in blood ROS, e-NO, and some pro-inflammatory mediators in bronchial secretions following erdostelne or placebo: a controlled study in current smokers with mild COPD. Pulm Pharmacol Ther, 2008,21:304-308.
  • 3Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev, 2004,56 : 515-548.
  • 4Brasier AR. The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovase Res, 2010,86: 211-218.
  • 5Di Stefano A, Caramori G, Oates T, et al. Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J, 2002, 20:556-563.
  • 6Caramori G, Romagnoli M, Casolari P, et al. Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Thorax, 2003, 58: 348-451.
  • 7Kersul AL,Iglesias A, Rios A, et al. Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol, 2011,47 : 176-183.
  • 8Isajevs S,Taivans I,Svirina D,et al. Patterns of inflammatory responses in large and small airways in smokers with and without chronic obstructive pulmonary disease. Respiration, 2011,81:362-371.
  • 9Imanifooladi AA, Yazdani S, Nourani MR. The role of nuclear faetor-kappaB in inflammatory lung disease. Inflamm Allergy Drug Targets, 2010,9 : 197-205.
  • 10Yanbaeva DG, Dentener MA, Creutzberg EC, et al. Systemic inflammation in COPD:is genetic susceptibility a key factor? COPD,2006,3: 51-61.

同被引文献25

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部